AR and prostate cancer: Considering the strong impact that gal or VNPT55 have in promoting the degradation of AR/AR-Vs proteins, and thus, their preclinical anti-prostate cancer activities and their efficacy in the clinic (vide supra), another important focus in this study was also to determine whether these compounds induce apoptosis in PC cells.